Literature DB >> 29141935

Pyoderma gangrenosum: combination therapy with excellent results in a patient with underlying hepatitis C.

Alfredo Iardino1, Orlando Garner1, Yasir Ahmed1, Kalpana Bhairavarasu1.   

Abstract

Entities:  

Keywords:  dermatology; drugs and medicines; hepatitis C; rheumatology; skin

Mesh：

Substances：

Year:  2017        PMID： 29141935      PMCID： PMC5695497          DOI： 10.1136/bcr-2017-223113

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


× No keyword cloud information.
  3 in total

1.  Intravenous immunoglobulin as adjunct therapy for refractory pyoderma gangrenosum: systematic review of cases and case series.

Authors:  H Song; N Lahood; A Mostaghimi
Journal:  Br J Dermatol       Date:  2018-01-09       Impact factor: 9.302

Review 2.  Pyoderma gangrenosum: an updated review.

Authors:  E Ruocco; S Sangiuliano; A G Gravina; A Miranda; G Nicoletti
Journal:  J Eur Acad Dermatol Venereol       Date:  2009-03-11       Impact factor: 6.166

3.  Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial.

Authors:  Anthony D Ormerod; Kim S Thomas; Fiona E Craig; Eleanor Mitchell; Nicola Greenlaw; John Norrie; James M Mason; Shernaz Walton; Graham A Johnston; Hywel C Williams
Journal:  BMJ       Date:  2015-06-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.